Accurate predictions of ovarian cancer outcome possible with new classification system
The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables...
Flatworm-inspired medical adhesives stop blood loss
Every year around two million people die worldwide from haemorrhaging or blood loss.
Uncontrolled haemorrhaging accounts for more than 30% of trauma deaths. To stop the bleeding, doctors often apply pressure to the wound and...
Superworms have the munchies for polystyrene
A species of worm with an appetite for polystyrene could be the key to plastic recycling on a mass scale.
Researchers at the University of Queensland have discovered the common Zophobas morio ‘superworm’ can eat through polystyrene,...
Safe’n’Spray: Winner at CPhI Festival of Pharma
Nemera’s concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October 2020 on the digital platform of CPhI Festival of Pharma.
Safe’n’Spray is...
UK accounts for over 12% of global cell and gene therapy clinical trials
The UK and the NHS are providing the right environment and infrastructure to allow innovative cell and gene therapies to reach patients. International companies recognise the appeal of the UK cell and gene therapy...
EVO NXT will restart on 5th an 6th April
Following the successful début in Málaga last year, preparations for the second EVO NXT Business Festival for next-generation products (NGPs) are in full swing. In its four zones, EVO NXT is not only going to provide...
£7m invested in fight against antimicrobial resistance
Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has announced £7m in new investment.
The financing was led by growth...
Hope for sufferers
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be a treatment for neurodegenerative diseases. Neurodegeneration, which involves the progressive loss of nerve structure and function, is a common...
GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs
GE Healthcare will provide Xiangxue Pharmaceutical Co., Ltd. (XPH) with a FlexFactory™ for cell therapy, a semi-automated end-to-end manufacturing platform, to help scale up, digitize and accelerate manufacturing processes for their cell therapy clinical...
Polyspecific antibodies for cancer research
AMSBIO announce a new range of high-quality bispecific antibodies (BsAbs) and trispecific antibodies (TsAbs) that can used to provide enhanced cancer therapeutic efficacy and/or safety compared to what can be achieved with conventional monospecific...
Mycoplasma, the Trojan Horse of cell culture!
Sonia Houghton, CEO Cryoniss
Mycoplasma are the smallest free-living organisms and considered to be the simplest form of bacteria, from the class Mollicutes.
The presence of Mycoplasma in cell culture has been well established, ever since...
Why Norwich is a UK hotspot for innovation in modern industrial biotechnology
The publication of a study commissioned by the Government Office for Science (GOS) earlier this year highlighted the East of England as a hotspot for biotechnology adoption and commercialisation. The study titled ‘Life Sciences...
Wellcome launches £250m Leap Fund to place big bets on bold research
Wellcome is to launch a new £250m fund that will place big bets on ambitious research programmes with the potential to fundamentally change science or transform health over a five- to ten-year horizon.
The Wellcome...
Organoid Cryopreservation Handbook
AMSBIO has published an informative handbook for scientists who need to preserve or archive organoids in a research lab.
The handbook brings together published paper citations, quotes and data from leading international research groups who...
Investigating Glycans – shedding new light on the ‘dark matter’ of biology
AMSBIO reports how the Faculty of Biological Sciences at the University of Leeds (UK) is using their specialty reagents for the production, visualization, and analysis of glycans and to investigate their interactions which are...
New material to treat wounds can protect against resistant bacteria
Researchers at Chalmers University of Technology, Sweden, have developed a new material that prevents infections in wounds – a specially designed hydrogel, that works against all types of bacteria, including antibiotic-resistant ones. The new...